NCT04978376

Brief Summary

Approximately 24 million older adults have prediabetes. Obesity, age related decreases in lean mass and increases in fat mass, and sedentary lifestyle have been associated with functional and cognitive decline in older adults. Innovative lifestyle strategies to treat obesity and pre-diabetes are critically needed. The proposed research will demonstrate that time restricted eating combined with resistance training is an effective non-pharmacological therapy to help obese prediabetic individuals reduce body fat, maintain lean mass, prevent progression of prediabetes to diabetes, and improve cognition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
3 years until next milestone

Results Posted

Study results publicly available

November 18, 2024

Completed
Last Updated

November 18, 2024

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

July 22, 2021

Results QC Date

April 21, 2023

Last Update Submit

September 16, 2024

Conditions

Keywords

Intermittent Fasting

Outcome Measures

Primary Outcomes (1)

  • Body Weight Changes Between Week 1 to Week 10

    Body weight assessed to the nearest 0.25 kg every week without shoes and in light clothing using a balance beam scale (HealthOMeter, Boca Raton, FL).

    Change from week 1 to week 10

Secondary Outcomes (3)

  • Body Composition Changes From Week 1 to Week 10

    Change from week 1 to week 10

  • Change in Insulin From Week 1 to Week 10

    Change from week 1 to week 10

  • Glucose

    Change from week 1 to week 10

Study Arms (4)

Time restricted eating

EXPERIMENTAL

ad-libitum eating between 12:00-20:00

Behavioral: Time restricted eating

TRE with endurance training

EXPERIMENTAL

ad-libitum eating between 12:00-20:00 with 3-5 days of supervised endurance exercise per week

Behavioral: Time restricted eating

TRE with resistance training

EXPERIMENTAL

ad-libitum eating between 12:00-20:00 with 3-5 days of supervised resistance training per week

Behavioral: Time restricted eating

Control

NO INTERVENTION

no change in diet or physical activity

Interventions

We will compare the effects of time restricted eating alone and combined with resistance exercise of endurance exercise versus a no intervention control group.

Also known as: resistance training, endurance exercise
TRE with endurance trainingTRE with resistance trainingTime restricted eating

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 50 to 70 years old
  • BMI between 25 and 50 kg/m2
  • Pre-diabetic or insulin resistant (fasting glucose: 100-125 mg/dl, HBA1c 5.7%-6.4%, or HOMA-IR \>2.5)
  • Sedentary or lightly active 24
  • Are post menopausal (absence of menstrual cycle for 1 year)

You may not qualify if:

  • Diabetic (fasting glucose: \>126 mg/dl or HBA1c \>6.5%)
  • Have a history of eating disorders (anorexia, bulimia, or binge eating disorder)
  • Have uncontrolled hypertension, any other cardiovascular disease, or history of aneurysm
  • History of alcohol dependance (score \>20 from Alcohol and Health Questionnaire)25
  • Are not weight stable for 3 months prior to the beginning of study (weight gain or loss \> 4 kg)
  • Are not able to keep a food diary or activity log for 7 consecutive days during screening
  • Are taking drugs that influence study outcomes (weight loss, glucose-lowering medications)
  • Are premenopausal, perimenopausal or have an irregular menstrual cycle (menses that does not appear every 27-32 days)
  • Mobility disability (unable to exercise for 40-60 minutes 3-5 days/week)
  • Diagnosed comorbidities including systemic diseases (Parkinson's cirrhosis, renal disease or systemic rheumatic conditions), cancer, or cognitive impairment
  • Are night shift workers
  • Are smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Glucose IntoleranceOverweightObesityIntermittent Fasting

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Kelsey Gabel
Organization
University of Illinois Chicago

Study Officials

  • Kelsey Gabel, PhD

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor and Postdoc

Study Record Dates

First Submitted

July 22, 2021

First Posted

July 27, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

November 18, 2024

Results First Posted

November 18, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations